Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A Case of Genital‐Predominant Inverse Psoriasis With Psoriatic Arthritis Treated With Sequential IL ‐23/ IL ‐17‐Targeted Biologic Therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Genital and Inverse/Intertriginous Psoriasis: An Updated Review of Therapies and Recommendations for Practical Management
10.1007/s13555-021-00536-6 · 2021 · External reference
Expert Consensus on Systemic Therapy for Plaque Psoriasis With Limited Skin Involvement in Japan: Results From a DELPHI Study
10.1111/1346-8138.17444 · 2025 · External reference
IL‐17 Responses Are the Dominant Inflammatory Signal Linking Inverse, Erythrodermic, and Chronic Plaque Psoriasis
10.1016/j.jid.2016.07.008 · 2016 · External reference
Anti‐IL‐23A mAb BI 655066 for Treatment of Moderate‐to‐Severe Psoriasis: Safety, Efficacy, Pharmacokinetics, and Biomarker Results of a Single‐Rising‐Dose, Randomized, Double‐Blind, Placebo‐Controlled Trial
10.1016/j.jaci.2015.01.018 · 2015 · External reference
Clinical Characteristics and Response to Biological Therapies for Inverse Psoriasis: A Real‐Life Comparison Between the Therapeutic Effects of Anti‐IL‐23 and Anti‐IL‐17 Agents
10.1111/ijd.17252 · 2024 · External reference
